In conclusion, hyperacetylation drives energetic dysfunction in T2D, and reversing acetylation with the SIRT3 activator honokiol rescued myocardial and mitochondrial energetics in T2D. The gene discussed is SIRT3; the disease is type 2 diabetes mellitus.